Pharmacy &
Quality Services
Our Research Pharmacist is dedicated to ensure the safe handling, preparation, and distribution of investigational products, adhering to the highest standards of quality and compliance. Our research pharmacy services include support in IMPD development and batch preparation protocols, as well as management of drug supply logistics, from receipt and storage to dispensing.
With a Qualified Person (QP) on staff, DELPHINIUM offers in-house expertise in GMP compliance, IMP release, and quality oversight. Our QP is directly involved in batch certification, vendor qualification, and quality risk management, and can support (sponsor) audits and regulatory inspections. This ensures not only timely and compliant release of investigational products, but also full inspection readiness throughout your study.
Our experienced Research Pharmacist collaborates closely with investigators and study coordinators to provide comprehensive support, ensuring medications are administered accurately and in strict accordance with study protocols. With DELPHINIUM’s pharmacy and quality services, you can be confident that your investigational products are managed with expertise and precision.
Research Pharmacist &
Qualified Person
Eline Hemelt, PharmD, has been working as a Research Pharmacist and Qualified Person for over 9 years. She brings extensive expertise and a proven track record in pharmaceutical development, clinical trial support, and GxP compliance. Eline combines regulatory knowledge with hands-on operational experience, ensuring that investigational medicinal products are managed in full compliance with applicable regulations and quality standards.
She is known for her collaborative mindset, attention to detail, and forward-thinking approach, working closely with sponsors and multidisciplinary teams to support efficient and compliant clinical trial execution. Her commitment to quality, reliability, and clear communication helps sponsors navigate complex regulatory environments with confidence.
I had the privilege of working with Eline Hemelt, who served as the Clinical Trial Pharmacist for our Phase 1 study conducted in 2021/22. Throughout the study, Eline Hemelt demonstrated exceptional professionalism and expertise. She oversaw all pharmaceutical aspects with outstanding care, regulatory rigor, adaptability, and efficiency. Her ability to navigate the unique requirements of our drug as a novel product was particularly noteworthy, and her performance was exemplary from start to finish. Her qualification as a QP was particularly valuable, enabling her to thoroughly understand the regulatory framework and ensure the study was handled in full compliance with all requirements.
~ Dr. Jonathan Zazoun, Head of CMC Omnix Medical Ltd.
